Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel A Funt

Showing results (1-10 of 78) with videos related to

Pageof 8
Sort By:
JCO Precision Oncology|February 6, 2026
Tale of Two Tumors: Drug Development in Urothelial and Germ Cell CancersSamuel A Funt
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2016
The Role of Neoadjuvant Trials in Drug Development for Solid TumorsSamuel A Funt, Paul B Chapman
Nature Reviews. Clinical Oncology|November 23, 2016
Systemic, perioperative management of muscle-invasive bladder cancer and future horizonsSamuel A Funt, Jonathan E Rosenberg
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2022
Reply to S. ZhangMichael Lattanzi, Samuel A Funt, Jonathan E Rosenberg
Oncology (Williston Park, N.Y.)|July 17, 2016
The Management of Advanced Germ Cell Tumors in 2016: The Memorial Sloan Kettering ApproachSamuel A Funt, Darren R Feldman, George J Bosl
European Urology Oncology|May 19, 2019
A New Twist to an Old Tale: Immunotherapy in Non-muscle-invasive Bladder CancerSamuel A Funt, Eugene J Pietzak, Dean F Bajorin
BJU International|July 2, 2020
'Case of the Month' from Memorial Sloan Kettering Cancer Center, New York, NY, USA: managing newly diagnosed metastatic testicular germ cell tumour in a COVID-19-positive patientNima Almassi, John P Mulhall, Samuel A Funt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2020
Reply to L.H. Einhorn et alDeaglan McHugh, George J Bosl, Samuel A Funt, et al.
The Journal of Urology|July 25, 2025
Optimizing the Approach to Surgical Decision-Making in Patients With Pure Seminoma Metastatic to the RetroperitoneumRichard S Matulewicz, Darren R Feldman, Joel Sheinfeld, et al.
Oncology (Williston Park, N.Y.)|November 13, 2014
CTLA-4 antibodies: new directions, new combinationsSamuel A Funt, David B Page, Jedd D Wolchok, et al.
Pageof 8

Showing results (1-10 of 78) with videos related to

Sort By:
Pageof 8
JCO Precision Oncology|February 6, 2026
Tale of Two Tumors: Drug Development in Urothelial and Germ Cell CancersSamuel A Funt
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2016
The Role of Neoadjuvant Trials in Drug Development for Solid TumorsSamuel A Funt, Paul B Chapman
Nature Reviews. Clinical Oncology|November 23, 2016
Systemic, perioperative management of muscle-invasive bladder cancer and future horizonsSamuel A Funt, Jonathan E Rosenberg
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2022
Reply to S. ZhangMichael Lattanzi, Samuel A Funt, Jonathan E Rosenberg
Oncology (Williston Park, N.Y.)|July 17, 2016
The Management of Advanced Germ Cell Tumors in 2016: The Memorial Sloan Kettering ApproachSamuel A Funt, Darren R Feldman, George J Bosl
European Urology Oncology|May 19, 2019
A New Twist to an Old Tale: Immunotherapy in Non-muscle-invasive Bladder CancerSamuel A Funt, Eugene J Pietzak, Dean F Bajorin
BJU International|July 2, 2020
'Case of the Month' from Memorial Sloan Kettering Cancer Center, New York, NY, USA: managing newly diagnosed metastatic testicular germ cell tumour in a COVID-19-positive patientNima Almassi, John P Mulhall, Samuel A Funt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2020
Reply to L.H. Einhorn et alDeaglan McHugh, George J Bosl, Samuel A Funt, et al.
The Journal of Urology|July 25, 2025
Optimizing the Approach to Surgical Decision-Making in Patients With Pure Seminoma Metastatic to the RetroperitoneumRichard S Matulewicz, Darren R Feldman, Joel Sheinfeld, et al.
Oncology (Williston Park, N.Y.)|November 13, 2014
CTLA-4 antibodies: new directions, new combinationsSamuel A Funt, David B Page, Jedd D Wolchok, et al.
Pageof 8